| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 927.358.475 $ | +139.812.396 $ | +184,4 % | 136 | 1.229.960.656 $ | +323.704.753 $ | +45,7 % | 137 | 1.280.024.683 $ | +640.637.939 $ | +333,0 % | 145 | |||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 140.044.248 $ | +75.550.577 $ | +117,1 % | 1 | 64.493.671 $ | +63.260.514 $ | +5.130,0 % | 1 | |||||
| Cidara Therapeutics, Inc. | → 0 | 126.623.645 $ | +100.030.710 $ | +376,2 % | 1 | ||||||||||
| Abivax S.A. | ABVX | → 0 | Neutral | 122.122.964 $ | +83.231.317 $ | +214,0 % | 1 | 38.891.647 $ | -7.108.253 $ | -15,5 % | 1 | 45.999.900 $ | +12.583.542 $ | +37,7 % | 1 |
| SPDR SERIES TRUST | → 0 | 47.475.000 $ | -54.709.000 $ | -53,5 % | 1 | 102.184.000 $ | -1.456.500 $ | -1,4 % | 1 | 103.640.500 $ | +28.490.500 $ | +37,9 % | 1 | ||
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 81.891.330 $ | +52.435.965 $ | +178,0 % | 1 | 29.455.365 $ | +11.122.138 $ | +60,7 % | 1 | ||||
| AMGEN INC | AMGN | → 0 | Stark | 80.190.951 $ | +80.190.951 $ | 1 | |||||||||
| INVESCO QQQ TRUST, SERIES 1 | QQQ | → 0 | 57.718.000 $ | +57.718.000 $ | 1 | ||||||||||
| Jazz Pharmaceuticals plc | JAZZ | → 0 | Neutral | 2.355.563 $ | -53.806.827 $ | -95,8 % | 1 | 56.162.390 $ | +36.590.089 $ | +186,9 % | 1 | ||||
| IONIS PHARMACEUTICALS INC | IONS | → 0 | Schwach | 55.503.000 $ | +37.546.127 $ | +209,1 % | 1 | 17.956.873 $ | -5.510.159 $ | -23,5 % | 1 | 23.467.032 $ | -4.563.018 $ | -16,3 % | 1 |
| Kodiak Sciences Inc. | KOD | → 0 | Schwach | 49.768.672 $ | -2.295.434 $ | -4,4 % | 1 | 52.064.106 $ | +31.938.861 $ | +158,7 % | 1 | 20.125.245 $ | +13.350.668 $ | +197,1 % | 1 |
| iSHARES TRUST | → 0 | 49.600.000 $ | +49.600.000 $ | 1 | |||||||||||
| ALUMIS INC. | ALMS | → 0 | Sehr schwach | 34.523.502 $ | +1.959.902 $ | +6,0 % | 1 | 32.563.600 $ | +30.503.264 $ | +1.480,5 % | 1 | 2.060.336 $ | +2.060.336 $ | 1 | |
| HARROW, INC. | HROW | → 0 | Neutral | 5.766.364 $ | -13.381.473 $ | -69,9 % | 1 | 19.147.837 $ | -14.811.466 $ | -43,6 % | 1 | 33.959.303 $ | +20.001.557 $ | +143,3 % | 1 |
| RAPT Therapeutics, Inc. | RAPT | → 0 | 32.355.028 $ | +11.980.928 $ | +58,8 % | 1 | |||||||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Sehr schwach | 31.383.884 $ | +8.321.202 $ | +36,1 % | 1 | 23.062.682 $ | -2.456.202 $ | -9,6 % | 1 | 25.518.884 $ | +18.704.621 $ | +274,5 % | 1 |
| BRISTOL MYERS SQUIBB CO | BMY | → 0 | Sehr stark | 2.448.850 $ | -27.876.150 $ | -91,9 % | 1 | 30.325.000 $ | -5.755.000 $ | -16,0 % | 1 | ||||
| Moderna, Inc. | MRNA | → 0 | Schwach | 28.012.000 $ | +28.012.000 $ | 1 | |||||||||
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 11.521.238 $ | -16.153.337 $ | -58,4 % | 1 | 27.674.575 $ | +8.608.265 $ | +45,1 % | 1 | |||||
| Maze Therapeutics, Inc. | MAZE | → 0 | Neutral | 11.309.331 $ | -433.629 $ | -3,7 % | 1 | 11.742.960 $ | -14.966.133 $ | -56,0 % | 1 | 26.709.093 $ | +7.499.501 $ | +39,0 % | 1 |
| CAPRICOR THERAPEUTICS, INC. | CAPR | → 0 | Sehr schwach | 22.977.497 $ | -3.714.159 $ | -13,9 % | 1 | 26.691.656 $ | +10.010.144 $ | +60,0 % | 1 | 16.681.512 $ | +13.331.443 $ | +397,9 % | 1 |
| OMEROS CORP | OMER | → 0 | Schwach | 25.762.504 $ | +25.762.504 $ | 1 | |||||||||
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 25.104.311 $ | +6.534.550 $ | +35,2 % | 1 | 18.569.761 $ | +14.133.261 $ | +318,6 % | 1 | ||||
| Vaxcyte, Inc. | PCVX | → 0 | Schwach | 22.594.085 $ | -2.316.626 $ | -9,3 % | 1 | 24.910.711 $ | +7.438.322 $ | +42,6 % | 1 | 17.472.389 $ | +5.993.464 $ | +52,2 % | 1 |
| Olema Pharmaceuticals, Inc. | OLMA | → 0 | Neutral | 7.296.845 $ | -9.821.043 $ | -57,4 % | 1 | 17.117.888 $ | -6.848.462 $ | -28,6 % | 1 | 23.966.350 $ | +23.966.350 $ | 1 | |
| ANI PHARMACEUTICALS INC | ANIP | → 0 | Stark | 22.523.196 $ | -322.641 $ | -1,4 % | 1 | 22.845.837 $ | +16.309.605 $ | +249,5 % | 1 | 6.536.232 $ | +6.536.232 $ | 1 | |
| Celldex Therapeutics, Inc. | CLDX | → 0 | Schwach | 22.046.925 $ | +3.800.090 $ | +20,8 % | 1 | 18.246.835 $ | +18.246.835 $ | 1 | |||||
| CORCEPT THERAPEUTICS INC | CORT | → 0 | Neutral | 20.396.036 $ | +20.396.036 $ | 1 | |||||||||
| RELMADA THERAPEUTICS, INC. | RLMD | → 0 | Neutral | 14.866.644 $ | -3.844.334 $ | -20,5 % | 1 | 18.710.978 $ | +3.890.803 $ | +26,3 % | 1 | 14.820.175 $ | +11.115.624 $ | +300,1 % | 1 |
| TENAX THERAPEUTICS, INC. | TENX | → 0 | Schwach | 17.128.260 $ | -970.821 $ | -5,4 % | 1 | 18.099.081 $ | +6.304.037 $ | +53,4 % | 1 | 11.795.044 $ | +4.431.608 $ | +60,2 % | 1 |
| Crinetics Pharmaceuticals, Inc. | CRNX | → 0 | 17.153.675 $ | +968.402 $ | +6,0 % | 1 | |||||||||
| Vera Therapeutics, Inc. | VERA | → 0 | Neutral | 16.378.747 $ | +5.448.257 $ | +49,8 % | 1 | 10.930.490 $ | +10.930.490 $ | 1 | |||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Schwach | 4.276.418 $ | -11.958.303 $ | -73,7 % | 1 | 16.234.721 $ | +13.535.555 $ | +501,5 % | 1 | ||||
| Fulcrum Therapeutics, Inc. | FULC | → 0 | Schwach | 3.839.929 $ | -4.207.136 $ | -52,3 % | 1 | 8.047.065 $ | -7.509.523 $ | -48,3 % | 1 | 15.556.588 $ | +3.695.718 $ | +31,2 % | 1 |
| Arcus Biosciences, Inc. | RCUS | → 0 | Neutral | 15.555.555 $ | +15.555.555 $ | 1 | |||||||||
| NEUROCRINE BIOSCIENCES INC | NBIX | → 0 | Stark | 14.900.943 $ | +14.900.943 $ | 1 | |||||||||
| ELI LILLY & Co | LLY | → 0 | Stark | 6.021.734 $ | -8.824.970 $ | -59,4 % | 1 | 14.846.704 $ | +14.846.704 $ | 1 | |||||
| NOVO NORDISK A S | NVO | → 0 | Stark | 14.700.000 $ | +6.376.500 $ | +76,6 % | 1 | ||||||||
| Karyopharm Therapeutics Inc. | KPTI | → 0 | Sehr schwach | 14.334.033 $ | +10.326.115 $ | +257,6 % | 1 | 4.007.918 $ | +3.829.657 $ | +2.148,3 % | 1 | ||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 14.322.251 $ | +14.160.270 $ | +8.741,9 % | 1 | ||||||||
| Connect Biopharma Holdings Ltd | CNTB | → 0 | Neutral | 10.801.710 $ | -2.694.977 $ | -20,0 % | 1 | 13.496.687 $ | -414.616 $ | -3,0 % | 1 | 13.911.303 $ | +13.911.303 $ | 1 | |
| Pharvaris N.V. | PHVS | → 0 | Neutral | 10.680.241 $ | -3.073.442 $ | -22,3 % | 1 | 13.753.683 $ | +243.428 $ | +1,8 % | 1 | 13.510.255 $ | +8.266.638 $ | +157,7 % | 1 |
| NewAmsterdam Pharma Co N.V. | NAMS | → 0 | Schwach | 13.556.000 $ | +11.948.284 $ | +743,2 % | 1 | 1.607.716 $ | -1.429.677 $ | -47,1 % | 1 | ||||
| CytomX Therapeutics, Inc. | CTMX | → 0 | Schwach | 13.515.344 $ | +2.756.699 $ | +25,6 % | 1 | ||||||||
| Contineum Therapeutics, Inc. | CTNM | → 0 | Neutral | 13.241.056 $ | +2.690.221 $ | +25,5 % | 1 | 10.550.835 $ | +7.317.585 $ | +226,3 % | 1 | 3.233.250 $ | +3.233.250 $ | 1 | |
| BRIGHT MINDS BIOSCIENCES INC. | DRUG | → 0 | Neutral | 6.244.361 $ | -5.915.871 $ | -48,6 % | 1 | 12.160.232 $ | -280.983 $ | -2,3 % | 1 | 12.441.215 $ | +11.505.171 $ | +1.229,1 % | 1 |
| Ultragenyx Pharmaceutical Inc. | RARE | → 0 | Schwach | 5.529.952 $ | -4.579.911 $ | -45,3 % | 1 | 10.109.863 $ | -1.798.870 $ | -15,1 % | 1 | 11.908.733 $ | +9.123.325 $ | +327,5 % | 1 |
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 11.871.130 $ | +11.871.130 $ | 1 | |||||||||
| Alto Neuroscience, Inc. | ANRO | → 0 | Neutral | 10.749.651 $ | -827.549 $ | -7,1 % | 1 | 11.577.200 $ | +2.410.199 $ | +26,3 % | 1 | 9.167.001 $ | +8.724.802 $ | +1.973,0 % | 1 |
| C4 Therapeutics, Inc. | CCCC | → 0 | Neutral | 11.362.110 $ | +11.362.110 $ | 1 | |||||||||
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | → 0 | Neutral | 11.271.040 $ | +7.665.790 $ | +212,6 % | 1 | 3.605.250 $ | +3.605.250 $ | 1 | |||||
| Biohaven Ltd. | BHVN | → 0 | Schwach | 11.132.933 $ | +7.643.344 $ | +219,0 % | 1 | 3.489.589 $ | +1.090.679 $ | +45,5 % | 1 | 2.398.910 $ | -9.555.054 $ | -79,9 % | 1 |
| EyePoint, Inc. | EYPT | → 0 | Neutral | 10.593.440 $ | +1.044.528 $ | +10,9 % | 1 | 9.548.912 $ | +9.548.912 $ | 1 | |||||
| SPRUCE BIOSCIENCES, INC. | SPRB | → 0 | Neutral | 6.553.224 $ | -1.377.390 $ | -17,4 % | 1 | 7.930.614 $ | -2.640.706 $ | -25,0 % | 1 | 10.571.320 $ | +10.451.998 $ | +8.759,5 % | 1 |
| Celcuity Inc. | CELC | → 0 | Schwach | 10.527.058 $ | +10.527.058 $ | 1 | |||||||||
| Apellis Pharmaceuticals, Inc. | APLS | → 0 | 9.981.357 $ | -8.346.724 $ | -45,5 % | 1 | |||||||||
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 9.495.694 $ | +2.297.191 $ | +31,9 % | 1 | 7.198.503 $ | +2.569.502 $ | +55,5 % | 1 | 4.629.001 $ | +4.629.001 $ | 1 | |
| DEXCOM INC | DXCM | → 0 | Neutral | 9.125.875 $ | +9.125.875 $ | 1 | |||||||||
| PTC THERAPEUTICS, INC. | PTCT | → 0 | Sehr stark | 9.013.186 $ | -21.276.038 $ | -70,2 % | 1 | ||||||||
| EUPRAXIA PHARMACEUTICALS INC. | EPRX | → 0 | Neutral | 5.352.388 $ | -3.442.338 $ | -39,1 % | 1 | 8.794.726 $ | +4.189.226 $ | +91,0 % | 1 | 4.605.500 $ | +4.605.500 $ | 1 | |
| Damora Therapeutics, Inc. | DMRA | → 0 | Neutral | 8.731.816 $ | +36.927 $ | +0,4 % | 1 | 8.694.889 $ | +2.120.702 $ | +32,3 % | 1 | 6.574.187 $ | +6.574.187 $ | 1 | |
| Ventyx Biosciences, Inc. | VTYX | → 0 | 8.657.097 $ | +4.584.228 $ | +112,6 % | 1 | |||||||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Sehr schwach | 1.666.581 $ | -6.694.219 $ | -80,1 % | 1 | 8.360.800 $ | +6.740.819 $ | +416,1 % | 1 | 1.619.981 $ | -410.785 $ | -20,2 % | 1 |
| CG Oncology, Inc. | CGON | → 0 | Schwach | 8.282.119 $ | -1.766.653 $ | -17,6 % | 1 | ||||||||
| Forte Biosciences, Inc. | FBRX | → 0 | 445.655 $ | -2.635.721 $ | -85,5 % | 1 | 3.081.376 $ | -5.099.625 $ | -62,3 % | 1 | 8.181.001 $ | +3.681.001 $ | +81,8 % | 1 | |
| PALVELLA THERAPEUTICS, INC. | PVLA | → 0 | Schwach | 8.055.631 $ | +3.996.705 $ | +98,5 % | 1 | ||||||||
| Q32 Bio Inc. | QTTB | → 0 | Neutral | 8.026.200 $ | +8.026.200 $ | 1 | |||||||||
| Pelthos Therapeutics Inc. | PTHS | → 0 | Schwach | 7.251.459 $ | +1.860.335 $ | +34,5 % | 1 | 5.391.124 $ | -2.537.374 $ | -32,0 % | 1 | 7.928.498 $ | +6.179.870 $ | +353,4 % | 1 |
| Inventiva S.A. | IVA | → 0 | Neutral | 4.152.521 $ | -3.690.260 $ | -47,1 % | 1 | 7.842.781 $ | +5.513.929 $ | +236,8 % | 1 | 2.328.852 $ | +2.328.852 $ | 1 | |
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Neutral | 7.807.251 $ | +2.508.973 $ | +47,4 % | 1 | ||||||||
| uniQure N.V. | QURE | → 0 | Neutral | 2.293.788 $ | -4.999.293 $ | -68,5 % | 1 | 7.293.081 $ | +2.591.793 $ | +55,1 % | 1 | 4.701.288 $ | -29.982.750 $ | -86,4 % | 1 |
| Mineralys Therapeutics, Inc. | MLYS | → 0 | Schwach | 7.257.999 $ | +7.257.999 $ | 1 | |||||||||
| Zura Bio Ltd | ZURA | → 0 | Neutral | 7.189.102 $ | +87.824 $ | +1,2 % | 1 | 7.101.278 $ | +2.897.111 $ | +68,9 % | 1 | 4.204.167 $ | -5.028.786 $ | -54,5 % | 1 |
| Ocugen, Inc. | OCGN | → 0 | Neutral | 6.063.348 $ | -1.109.631 $ | -15,5 % | 1 | 7.172.979 $ | +7.172.979 $ | 1 | |||||
| Tectonic Therapeutic, Inc. | TECX | → 0 | Neutral | 7.075.647 $ | +2.206.178 $ | +45,3 % | 1 | 4.869.469 $ | +4.869.469 $ | 1 | |||||
| AGIOS PHARMACEUTICALS, INC. | AGIO | → 0 | Neutral | 6.878.195 $ | -4.239.742 $ | -38,1 % | 1 | ||||||||
| Alpha Cognition Inc. | ACOG | → 0 | Neutral | 6.037.790 $ | +238.928 $ | +4,1 % | 1 | 5.798.862 $ | -1.066.823 $ | -15,5 % | 1 | 6.865.685 $ | +705.539 $ | +11,5 % | 1 |
| Invivyd, Inc. | IVVD | → 0 | Neutral | 2.317.592 $ | -1.135.950 $ | -32,9 % | 1 | 3.453.542 $ | -3.108.185 $ | -47,4 % | 1 | 6.561.727 $ | +4.275.150 $ | +187,0 % | 1 |
| Hims & Hers Health, Inc. | HIMS | → 0 | Neutral | 6.531.170 $ | +6.531.170 $ | 1 | |||||||||
| Ovid Therapeutics Inc. | OVID | → 0 | Neutral | 6.105.503 $ | -320.739 $ | -5,0 % | 1 | 6.426.242 $ | +6.022.722 $ | +1.492,5 % | 1 | 403.520 $ | -1.020.727 $ | -71,7 % | 1 |
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 6.421.957 $ | +3.140.917 $ | +95,7 % | 1 | 3.281.040 $ | +3.281.040 $ | 1 | |||||
| ProQR Therapeutics N.V. | PRQR | → 0 | Neutral | 6.372.230 $ | +3.954.819 $ | +163,6 % | 1 | 2.417.411 $ | -596.890 $ | -19,8 % | 1 | 3.014.301 $ | +1.113.854 $ | +58,6 % | 1 |
| Nuvalent, Inc. | NUVL | → 0 | 2.417.206 $ | -3.577.355 $ | -59,7 % | 1 | 5.994.561 $ | +5.994.561 $ | 1 | ||||||
| Kymera Therapeutics, Inc. | KYMR | → 0 | Neutral | 5.779.368 $ | +1.581.552 $ | +37,7 % | 1 | 4.197.816 $ | +4.197.816 $ | 1 | |||||
| KAZIA THERAPEUTICS LTD | KZIA | → 0 | Schwach | 5.578.510 $ | +5.578.510 $ | 1 | |||||||||
| SELLAS Life Sciences Group, Inc. | SLS | → 0 | Neutral | 5.235.372 $ | +5.235.372 $ | 1 | |||||||||
| Lexeo Therapeutics, Inc. | LXEO | → 0 | Neutral | 2.388.066 $ | -556.617 $ | -18,9 % | 1 | 2.944.683 $ | -2.149.516 $ | -42,2 % | 1 | 5.094.199 $ | +1.325.329 $ | +35,2 % | 1 |
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 5.042.607 $ | +3.555.798 $ | +239,2 % | 1 | 1.486.809 $ | +1.486.809 $ | 1 | |||||
| Legend Biotech Corp | LEGN | → 0 | Neutral | 4.104.404 $ | -828.142 $ | -16,8 % | 1 | 4.932.546 $ | +4.932.546 $ | 1 | |||||
| BioAge Labs, Inc. | BIOA | → 0 | Neutral | 4.901.999 $ | +4.901.999 $ | 1 | |||||||||
| PepGen Inc. | PEPG | → 0 | Neutral | 804.897 $ | -517.585 $ | -39,1 % | 1 | 1.322.482 $ | -3.541.561 $ | -72,8 % | 1 | 4.864.043 $ | +2.387.875 $ | +96,4 % | 1 |
| Rezolute, Inc. | RZLT | → 0 | Neutral | 4.862.062 $ | +4.811.801 $ | +9.573,6 % | 1 | 50.261 $ | +11.370 $ | +29,2 % | 1 | 38.891 $ | +38.891 $ | 1 | |
| Sionna Therapeutics, Inc. | SION | → 0 | Schwach | 4.728.925 $ | +4.728.925 $ | 1 | |||||||||
| Alector, Inc. | ALEC | → 0 | Neutral | 3.985.038 $ | -492.565 $ | -11,0 % | 1 | 4.477.603 $ | +1.228.737 $ | +37,8 % | 1 | 3.248.866 $ | +999.265 $ | +44,4 % | 1 |
| Monopar Therapeutics | MNPR | → 0 | Schwach | 4.431.450 $ | +4.431.450 $ | 1 | |||||||||
| DELCATH SYSTEMS, INC. | DCTH | → 0 | Stark | 2.337.548 $ | -1.664.461 $ | -41,6 % | 1 | 4.002.009 $ | -353.626 $ | -8,1 % | 1 | 4.355.635 $ | -280.314 $ | -6,0 % | 1 |
| Compass Therapeutics, Inc. | CMPX | → 0 | Neutral | 39.419 $ | -55.801 $ | -58,6 % | 1 | 95.220 $ | -4.200.780 $ | -97,8 % | 1 | 4.296.000 $ | +4.296.000 $ | 1 | |
| ADMA BIOLOGICS, INC. | ADMA | → 0 | Stark | 4.283.737 $ | +1.940.277 $ | +82,8 % | 1 | ||||||||
| ARVINAS, INC. | ARVN | → 0 | Neutral | 2.977.115 $ | -820.409 $ | -21,6 % | 1 | 3.797.524 $ | -451.405 $ | -10,6 % | 1 | 4.248.929 $ | +2.321.219 $ | +120,4 % | 1 |
| Absci Corp | ABSI | → 0 | Neutral | 4.100.217 $ | +4.100.217 $ | 1 | |||||||||
| Lipocine Inc. | LPCN | → 0 | Neutral | 1.301.902 $ | -2.761.460 $ | -68,0 % | 1 | 4.063.362 $ | +2.461.040 $ | +153,6 % | 1 | 1.602.322 $ | +1.602.322 $ | 1 | |
| Climb Bio, Inc. | CLYM | → 0 | Neutral | 3.912.000 $ | +3.912.000 $ | 1 | |||||||||
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 212.250 $ | -3.520.500 $ | -94,3 % | 1 | 3.732.750 $ | +972.750 $ | +35,2 % | 1 | 2.760.000 $ | +468.000 $ | +20,4 % | 1 |
| Cardiol Therapeutics Inc. | CRDL | → 0 | Neutral | 3.524.500 $ | -154.250 $ | -4,2 % | 1 | 3.678.750 $ | +3.678.750 $ | 1 | |||||
| Krystal Biotech, Inc. | KRYS | → 0 | Stark | 3.652.243 $ | -658.796 $ | -15,3 % | 1 | ||||||||
| TG THERAPEUTICS, INC. | TGTX | → 0 | Neutral | 3.514.689 $ | -2.805.705 $ | -44,4 % | 1 | ||||||||
| Vir Biotechnology, Inc. | VIR | → 0 | Neutral | 2.627.591 $ | -843.952 $ | -24,3 % | 1 | 3.471.543 $ | +83.376 $ | +2,5 % | 1 | ||||
| Zenas BioPharma, Inc. | ZBIO | → 0 | Neutral | 3.398.616 $ | +3.398.616 $ | 1 | |||||||||
| NextCure, Inc. | NXTC | → 0 | Schwach | 461.284 $ | -2.045.663 $ | -81,6 % | 1 | 2.506.947 $ | -874.573 $ | -25,9 % | 1 | 3.381.520 $ | +3.381.520 $ | 1 | |
| Solid Biosciences Inc. | SLDB | → 0 | Neutral | 429.130 $ | -1.474.614 $ | -77,5 % | 1 | 1.903.744 $ | -1.392.323 $ | -42,2 % | 1 | 3.296.067 $ | -681.670 $ | -17,1 % | 1 |
| Cue Biopharma, Inc. | CUE | → 0 | Schwach | 3.293.728 $ | +3.293.728 $ | 1 | |||||||||
| CUMBERLAND PHARMACEUTICALS INC | CPIX | → 0 | Stark | 3.260.431 $ | +1.462.683 $ | +81,4 % | 1 | 1.797.748 $ | -414.861 $ | -18,7 % | 1 | 2.212.609 $ | +478.101 $ | +27,6 % | 1 |
| Aquestive Therapeutics, Inc. | AQST | → 0 | Neutral | 3.230.000 $ | +3.230.000 $ | 1 | |||||||||
| Annexon, Inc. | ANNX | → 0 | Neutral | 2.456.693 $ | -757.858 $ | -23,6 % | 1 | 3.214.551 $ | +2.058.725 $ | +178,1 % | 1 | 1.155.826 $ | +1.155.826 $ | 1 | |
| Freenome, Inc. | FRNM | → 0 | Schwach | 2.643.232 $ | -496.360 $ | -15,8 % | 1 | 3.139.592 $ | +3.139.592 $ | 1 | |||||
| INSMED Inc | INSM | → 0 | Schwach | 689.074 $ | -2.432.682 $ | -77,9 % | 1 | 3.121.756 $ | -27.660.525 $ | -89,9 % | 1 | ||||
| Gossamer Bio, Inc. | GOSS | → 0 | Sehr schwach | 3.100.000 $ | +3.100.000 $ | 1 | |||||||||
| NEKTAR THERAPEUTICS | NKTR | → 0 | Schwach | 3.069.528 $ | +3.069.528 $ | 1 | |||||||||
| Rein Therapeutics, Inc. | RNTX | → 0 | Schwach | 3.068.000 $ | +3.068.000 $ | 1 | |||||||||
| Quoin Pharmaceuticals Ltd. | QNRX | → 0 | Neutral | 1.023.844 $ | -372.307 $ | -26,7 % | 1 | 1.396.151 $ | -1.656.342 $ | -54,3 % | 1 | 3.052.493 $ | +3.052.493 $ | 1 | |
| Kalaris Therapeutics, Inc. | KLRS | → 0 | Schwach | 1.465.201 $ | -611.999 $ | -29,5 % | 1 | 2.077.200 $ | -961.201 $ | -31,6 % | 1 | 3.038.401 $ | +3.038.401 $ | 1 | |
| Acumen Pharmaceuticals, Inc. | ABOS | → 0 | Neutral | 2.813.638 $ | +326.678 $ | +13,1 % | 1 | 2.486.960 $ | +1.950.361 $ | +363,5 % | 1 | 536.599 $ | +82.134 $ | +18,1 % | 1 |
| BridgeBio Oncology Therapeutics, Inc. | BBOT | → 0 | Schwach | 2.418.568 $ | -338.723 $ | -12,3 % | 1 | 2.757.291 $ | -82.483 $ | -2,9 % | 1 | ||||
| Erasca, Inc. | ERAS | → 0 | Neutral | 2.735.673 $ | +2.735.673 $ | 1 | |||||||||
| ProMIS Neurosciences Inc. | PMN | → 0 | Neutral | 2.697.801 $ | +1.999.301 $ | +286,2 % | 1 | 698.500 $ | +698.500 $ | 1 | |||||
| Tarsus Pharmaceuticals, Inc. | TARS | → 0 | Schwach | 1.961.588 $ | -224.707 $ | -10,3 % | 1 | 2.186.295 $ | -365.577 $ | -14,3 % | 1 | 2.551.872 $ | -1.823.306 $ | -41,7 % | 1 |
| Neumora Therapeutics, Inc. | NMRA | → 0 | Neutral | 2.173.294 $ | -319.602 $ | -12,8 % | 1 | 2.492.896 $ | +204.545 $ | +8,9 % | 1 | 2.288.351 $ | +2.265.604 $ | +9.960,0 % | 1 |
| Cabaletta Bio, Inc. | CABA | → 0 | Neutral | 2.177.000 $ | -244.000 $ | -10,1 % | 1 | 2.421.000 $ | +450.000 $ | +22,8 % | 1 | 1.971.000 $ | +1.971.000 $ | 1 | |
| FRACTYL HEALTH, INC. | GUTS | → 0 | Sehr schwach | 873.840 $ | +370.260 $ | +73,5 % | 1 | 503.580 $ | -1.916.421 $ | -79,2 % | 1 | 2.420.001 $ | -441.999 $ | -15,4 % | 1 |
| Replimune Group, Inc. | REPL | → 0 | Neutral | 2.295.000 $ | +2.295.000 $ | 1 | |||||||||
| DBV Technologies S.A. | DBVT | → 0 | Schwach | 1.690.953 $ | -507.823 $ | -23,1 % | 1 | 2.198.776 $ | +114.537 $ | +5,5 % | 1 | 2.084.239 $ | +2.084.239 $ | 1 | |
| Amylyx Pharmaceuticals, Inc. | AMLX | → 0 | Stark | 2.110.301 $ | +2.110.301 $ | 1 | |||||||||
| Anteris Technologies Global Corp. | AVR | → 0 | Neutral | 1.640.724 $ | -393.745 $ | -19,4 % | 1 | 2.034.469 $ | +2.034.469 $ | 1 | |||||
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 1.945.524 $ | +1.945.524 $ | 1 | |||||||||
| Journey Medical Corp | DERM | → 0 | Neutral | 1.780.168 $ | +600.933 $ | +51,0 % | 1 | 1.179.235 $ | -759.337 $ | -39,2 % | 1 | 1.938.572 $ | +1.938.572 $ | 1 | |
| iBio, Inc. | IBIO | → 0 | Neutral | 1.674.859 $ | -143.559 $ | -7,9 % | 1 | 1.818.418 $ | -28.712 $ | -1,6 % | 1 | 1.847.130 $ | +1.336.107 $ | +261,5 % | 1 |
| Silence Therapeutics plc | SLN | → 0 | Neutral | 1.827.725 $ | +96.157 $ | +5,6 % | 1 | 1.731.568 $ | +0 $ | +0,0 % | 1 | 1.731.568 $ | +425.432 $ | +32,6 % | 1 |
| Verastem, Inc. | VSTM | → 0 | Neutral | 816.965 $ | -316.519 $ | -27,9 % | 1 | 1.133.484 $ | -517.555 $ | -31,3 % | 1 | 1.651.039 $ | +1.651.039 $ | 1 | |
| PALISADE BIO, INC. | PALI | → 0 | Neutral | 1.567.500 $ | +1.086.288 $ | +225,7 % | 1 | 481.212 $ | -164.987 $ | -25,5 % | 1 | 646.199 $ | +646.199 $ | 1 | |
| Amanat Acquisition Corp. | AMAN | → 0 | 1.524.000 $ | +1.524.000 $ | 1 | ||||||||||
| Wave Life Sciences, Inc. | WVE | → 0 | 495.507 $ | -122.810 $ | -19,9 % | 1 | 618.317 $ | -831.528 $ | -57,4 % | 1 | 1.449.845 $ | +747.455 $ | +106,4 % | 1 | |
| Travere Therapeutics, Inc. | TVTX | → 0 | Neutral | 1.398.486 $ | -8.287.730 $ | -85,6 % | 1 | ||||||||
| CATALYST PHARMACEUTICALS, INC. | CPRX | → 0 | 1.339.436 $ | -953.408 $ | -41,6 % | 1 | |||||||||
| IRulya Therapeutics Inc. | IRLA | → 0 | Schwach | 1.314.245 $ | +1.314.245 $ | 1 | |||||||||
| Immunome Inc. | IMNM | → 0 | Schwach | 1.271.401 $ | +1.271.401 $ | 1 | |||||||||
| Lyell Immunopharma, Inc. | LYEL | → 0 | Schwach | 577.188 $ | -246.896 $ | -30,0 % | 1 | 824.084 $ | -440.389 $ | -34,8 % | 1 | 1.264.473 $ | +553.177 $ | +77,8 % | 1 |
| Traws Pharma, Inc. | TRAW | → 0 | 403.217 $ | -837.783 $ | -67,5 % | 1 | 1.241.000 $ | +474.701 $ | +61,9 % | 1 | 766.299 $ | +713.587 $ | +1.353,7 % | 1 | |
| Elicio Therapeutics, Inc. | ELTX | → 0 | Neutral | 1.228.522 $ | +1.228.522 $ | 1 | |||||||||
| PLIANT THERAPEUTICS, INC. | PLRX | → 0 | Neutral | 1.140.000 $ | +1.140.000 $ | 1 | |||||||||
| Definium Therapeutics, Inc. | DFTX | → 0 | Neutral | 1.111.377 $ | +324.004 $ | +41,2 % | 1 | 787.373 $ | +48.245 $ | +6,5 % | 1 | ||||
| Helus Pharma Inc. | HELP | → 0 | Neutral | 873.532 $ | +239.198 $ | +37,7 % | 1 | 634.334 $ | -446.678 $ | -41,3 % | 1 | 1.081.012 $ | +253.614 $ | +30,7 % | 1 |
| IMMUNIC, INC. | IMUX | → 0 | Schwach | 1.036.922 $ | +288.046 $ | +38,5 % | 1 | 748.876 $ | +388.809 $ | +108,0 % | 1 | 360.067 $ | -445.865 $ | -55,3 % | 1 |
| Neuronetics, Inc. | STIM | → 0 | Schwach | 911.537 $ | -105.177 $ | -10,3 % | 1 | 1.016.714 $ | +49.083 $ | +5,1 % | 1 | 967.631 $ | -1.504.974 $ | -60,9 % | 1 |
| Equillium, Inc. | EQ | → 0 | Neutral | 971.376 $ | +364.266 $ | +60,0 % | 1 | 607.110 $ | +136.600 $ | +29,0 % | 1 | 470.510 $ | -4.675 $ | -1,0 % | 1 |
| Faeth Therapeutics, Inc. | FTH | → 0 | Schwach | 884.650 $ | +684.466 $ | +341,9 % | 1 | 200.184 $ | -27.631 $ | -12,1 % | 1 | 227.815 $ | +15.219 $ | +7,2 % | 1 |
| First Tracks Biotherapeutics, Inc. | TRAX | → 0 | Neutral | 860.633 $ | +860.633 $ | 1 | |||||||||
| IO Biotech, Inc. | IOBT | → 0 | 81.391 $ | -762.888 $ | -90,4 % | 1 | 844.279 $ | +290.228 $ | +52,4 % | 1 | |||||
| Kezar Life Sciences, Inc. | KZR | → 0 | 758.405 $ | +115.498 $ | +18,0 % | 1 | 642.907 $ | +225.993 $ | +54,2 % | 1 | |||||
| Centessa Pharmaceuticals plc | CNTA | → 0 | 719.448 $ | -6.742.277 $ | -90,4 % | 1 | |||||||||
| ACADIA PHARMACEUTICALS INC | ACAD | → 0 | Neutral | 710.905 $ | +85.421 $ | +13,7 % | 1 | 625.484 $ | +625.484 $ | 1 | |||||
| KalVista Pharmaceuticals, Inc. | KALV | → 0 | 706.946 $ | +139.773 $ | +24,6 % | 1 | 567.173 $ | -4.304.827 $ | -88,4 % | 1 | |||||
| CNS Pharmaceuticals, Inc. | CNSP | → 0 | 649.267 $ | +539.275 $ | +490,3 % | 1 | 109.992 $ | -130.616 $ | -54,3 % | 1 | 240.608 $ | +240.608 $ | 1 | ||
| Passage BIO, Inc. | PASG | → 0 | 485.643 $ | -49.130 $ | -9,2 % | 1 | 534.773 $ | +534.773 $ | 1 | ||||||
| SANGAMO THERAPEUTICS, INC | SGMO | → 0 | 300.890 $ | -210.952 $ | -41,2 % | 1 | 511.842 $ | -359.977 $ | -41,3 % | 1 | |||||
| Immatics N.V. | IMTX | → 0 | Neutral | 492.003 $ | +14.084 $ | +2,9 % | 1 | 477.919 $ | -32.057 $ | -6,3 % | 1 | 509.976 $ | +89.122 $ | +21,2 % | 1 |
| LEXICON PHARMACEUTICALS, INC. | LXRX | → 0 | Neutral | 395.218 $ | +138.326 $ | +53,8 % | 1 | 256.892 $ | +67.516 $ | +35,7 % | 1 | 189.376 $ | -48.871 $ | -20,5 % | 1 |
| Adlai Nortye Group Ltd. | ANL | → 0 | Neutral | 389.839 $ | +155.258 $ | +66,2 % | 1 | 234.581 $ | +234.581 $ | 1 | |||||
| InMed Pharmaceuticals Inc. | INM | → 0 | 379.788 $ | +379.788 $ | 1 | ||||||||||
| Viking Therapeutics, Inc. | VKTX | → 0 | Schwach | 379.061 $ | +62.870 $ | +19,9 % | 1 | 316.191 $ | -25.653 $ | -7,5 % | 1 | 341.844 $ | +79.044 $ | +30,1 % | 1 |
| Evaxion A/S | EVAX | → 0 | Neutral | 231.564 $ | -46.312 $ | -16,7 % | 1 | 277.876 $ | -78.434 $ | -22,0 % | 1 | 356.310 $ | +55.509 $ | +18,5 % | 1 |
| MACROGENICS INC | MGNX | → 0 | Neutral | 346.006 $ | +129.565 $ | +59,9 % | 1 | 216.441 $ | +95.863 $ | +79,5 % | 1 | 120.578 $ | -13.941 $ | -10,4 % | 1 |
| Vistagen Therapeutics, Inc. | VTGN | → 0 | Sehr schwach | 117.311 $ | -179.343 $ | -60,5 % | 1 | 296.654 $ | -46.922 $ | -13,7 % | 1 | 343.576 $ | -1.860.508 $ | -84,4 % | 1 |
| Structure Therapeutics Inc. | GPCR | → 0 | Schwach | 335.510 $ | -4.235.126 $ | -92,7 % | 1 | ||||||||
| VERU INC. | VERU | → 0 | Neutral | 295.073 $ | +9.347 $ | +3,3 % | 1 | 285.726 $ | -255.862 $ | -47,2 % | 1 | ||||
| Hyperliquid Strategies Inc | PURR | → 0 | Neutral | 236.108 $ | +83.403 $ | +54,6 % | 1 | 152.705 $ | +45.901 $ | +43,0 % | 1 | 106.804 $ | +106.804 $ | 1 | |
| Nyxoah SA | NYXH | → 0 | Neutral | 80.035 $ | -58.250 $ | -42,1 % | 1 | 138.285 $ | -79.561 $ | -36,5 % | 1 | 217.846 $ | -15.037 $ | -6,5 % | 1 |
| Cartesian Therapeutics, Inc. | RNAC | → 0 | Neutral | 216.809 $ | +88.846 $ | +69,4 % | 1 | 127.963 $ | -22.055 $ | -14,7 % | 1 | 150.018 $ | -76.519 $ | -33,8 % | 1 |
| Voyager Therapeutics, Inc. | VYGR | → 0 | Schwach | 185.722 $ | -19.101 $ | -9,3 % | 1 | 204.823 $ | -3.715 $ | -1,8 % | 1 | 208.538 $ | -51.890 $ | -19,9 % | 1 |
| Neuphoria Therapeutics Inc. | NEUP | → 0 | 207.326 $ | +14.233 $ | +7,4 % | 1 | 193.093 $ | +9.014 $ | +4,9 % | 1 | 184.079 $ | +184.079 $ | 1 | ||
| Glucotrack, Inc. | GCTK | → 0 | Sehr schwach | 14.621 $ | -15.169 $ | -50,9 % | 1 | 29.790 $ | -147.572 $ | -83,2 % | 1 | 177.362 $ | +177.362 $ | 1 | |
| Yarrow Bioscience, Inc. | YARW | → 0 | Schwach | 172.379 $ | +14.095 $ | +8,9 % | 1 | 158.284 $ | +4.609 $ | +3,0 % | 1 | 153.675 $ | +56.526 $ | +58,2 % | 1 |
| BIOCRYST PHARMACEUTICALS INC | BCRX | → 0 | Stark | 167.560 $ | +167.560 $ | 1 | |||||||||
| Enveric Biosciences, Inc. | ENVB | → 0 | 138.003 $ | +138.003 $ | 1 | ||||||||||
| Shuttle Pharmaceuticals Holdings, Inc. | SHPH | → 0 | Schwach | 46.832 $ | -77.355 $ | -62,3 % | 1 | 124.187 $ | +124.187 $ | 1 | |||||
| PMV Pharmaceuticals, Inc. | PMVP | → 0 | Neutral | 119.442 $ | +8.913 $ | +8,1 % | 1 | 110.529 $ | -892 $ | -0,8 % | 1 | 111.421 $ | -25.079 $ | -18,4 % | 1 |
| MANGOCEUTICALS, INC. | MGRX | → 0 | Sehr schwach | 52.496 $ | +2.749 $ | +5,5 % | 1 | 49.747 $ | -52.482 $ | -51,3 % | 1 | 102.229 $ | +102.229 $ | 1 | |
| Chemomab Therapeutics Ltd. | CMMB | → 0 | 83.904 $ | +2.589 $ | +3,2 % | 1 | 81.315 $ | -4.143 $ | -4,8 % | 1 | 85.458 $ | -54.621 $ | -39,0 % | 1 | |
| Airsculpt Technologies, Inc. | AIRS | → 0 | Schwach | 73.792 $ | +27.387 $ | +59,0 % | 1 | 46.405 $ | +13.937 $ | +42,9 % | 1 | 32.468 $ | -111.499 $ | -77,4 % | 1 |
| Tessera Defense & Homeland Security Inc. | HLSQ | → 0 | Sehr schwach | 6.773 $ | -66.329 $ | -90,7 % | 1 | 73.102 $ | +36.688 $ | +100,8 % | 1 | 36.414 $ | -169.898 $ | -82,4 % | 1 |
| Lyra Therapeutics, Inc. | LYRA | → 0 | 65.176 $ | -74.276 $ | -53,3 % | 1 | |||||||||
| Jasper Therapeutics, Inc. | JSPR | → 0 | Sehr schwach | 10.144 $ | -10.966 $ | -51,9 % | 1 | 21.110 $ | -22.980 $ | -52,1 % | 1 | 44.090 $ | -15.664 $ | -26,2 % | 1 |
| AETHLON MEDICAL INC | AEMD | → 0 | Schwach | 11.827 $ | -19.631 $ | -62,4 % | 1 | 31.458 $ | -8.330 $ | -20,9 % | 1 | 39.788 $ | -75.256 $ | -65,4 % | 1 |
| Theriva Biologics, Inc. | TOVX | → 0 | 28.041 $ | +6.097 $ | +27,8 % | 1 | 21.944 $ | -1.636 $ | -6,9 % | 1 | 23.580 $ | -25.045 $ | -51,5 % | 1 | |
| SYNLOGIC, INC. | SYBX | → 0 | 22.362 $ | -12.151 $ | -35,2 % | 1 | |||||||||
| Anebulo Pharmaceuticals, Inc. | ANEB | → 0 | 17.913 $ | -376.387 $ | -95,5 % | 1 | |||||||||
| Autonomix Medical, Inc. | AMIX | → 0 | Neutral | 7.290 $ | -2.988 $ | -29,1 % | 1 | 10.278 $ | -11.323 $ | -52,4 % | 1 | ||||
| Gesamt | 927.358.475 $ | +139.812.396 $ | +184,4 % | 136 | 1.229.960.656 $ | +323.704.753 $ | +45,7 % | 137 | 1.280.024.683 $ | +640.637.939 $ | +333,0 % | 145 | |||